These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro. Gerber AU; Wiprächtiger P; Stettler-Spichiger U; Lebek G J Infect Dis; 1982 Apr; 145(4):554-60. PubMed ID: 6802906 [TBL] [Abstract][Full Text] [Related]
5. Bactericidal effect of gentamicin trough concentration provides a rationale for administration of bolus doses and maintenance of trough levels. McLean AJ; Bastone EB; Ioannides-Demos LL; Spicer WJ J Antimicrob Chemother; 1994 May; 33(5):999-1004. PubMed ID: 8089073 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal effect of gentamicin peak concentration provides a rationale for administration of bolus doses. McLean AJ; IoannidesDemos LL; Li SC; Bastone EB; Spicer WJ J Antimicrob Chemother; 1993 Aug; 32(2):301-5. PubMed ID: 8226432 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model. Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection. Blaser J J Antimicrob Chemother; 1991 May; 27 Suppl C():21-8. PubMed ID: 1906863 [TBL] [Abstract][Full Text] [Related]
10. Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model. Zhuang L; He Y; Xia H; Liu Y; Sy SK; Derendorf H J Antimicrob Chemother; 2016 Apr; 71(4):1012-21. PubMed ID: 26702923 [TBL] [Abstract][Full Text] [Related]
11. Validation of a dosage individualization table for extended-interval gentamicin in neonates. Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714 [TBL] [Abstract][Full Text] [Related]
12. Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing. Bastone EB; Li SC; Ioannides-Demos LL; Spicer WJ; McLean AJ Antimicrob Agents Chemother; 1993 Apr; 37(4):914-7. PubMed ID: 8494392 [TBL] [Abstract][Full Text] [Related]
13. Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve. Tisdale JE; Pasko MT; Mylotte JM Antimicrob Agents Chemother; 1989 Sep; 33(9):1500-5. PubMed ID: 2510592 [TBL] [Abstract][Full Text] [Related]
14. [In vitro study on the problem of optimal gentamicin therapy in leukopenic patients: short injections or parenteral infusions?]. Gerber A; Wiprächtiger P; Spichiger U; Lebek G Schweiz Med Wochenschr; 1979 Dec; 109(47):1902-3. PubMed ID: 119319 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. Roos JF; Bulitta J; Lipman J; Kirkpatrick CM J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209 [TBL] [Abstract][Full Text] [Related]
16. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Mouton JW; den Hollander JG Antimicrob Agents Chemother; 1994 May; 38(5):931-6. PubMed ID: 8067772 [TBL] [Abstract][Full Text] [Related]
17. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age. Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209 [TBL] [Abstract][Full Text] [Related]
18. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Barclay ML; Begg EJ; Chambers ST Antimicrob Agents Chemother; 1992 Sep; 36(9):1951-7. PubMed ID: 1416886 [TBL] [Abstract][Full Text] [Related]